Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults.
Cantarini L, Iacoponi F, Lucherini OM, Obici L, Brizi MG, Cimaz R, Rigante D, Benucci M, Sebastiani GD, Brucato A, Sabadini L, Simonini G, Giani T, Laghi Pasini F, Baldari CT, Bellisai F, Valentini G, Bombardieri S, Paolazzi G, Galeazzi M. Cantarini L, et al. Among authors: cimaz r. Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3):695-702. doi: 10.1177/039463201102400315. Int J Immunopathol Pharmacol. 2011. PMID: 21978701 Free article.
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.
Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G. Blandizzi C, et al. Among authors: cimaz r. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10. doi: 10.1177/03946320140270S101. Int J Immunopathol Pharmacol. 2014. PMID: 24774503 Free article. Review.
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.
Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R. Armuzzi A, et al. Among authors: cimaz r. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):11-32. doi: 10.1177/03946320140270S102. Int J Immunopathol Pharmacol. 2014. PMID: 24774504 Free article. Review.
Adalimumab in the treatment of immune-mediated diseases.
Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C. Lapadula G, et al. Among authors: cimaz r. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48. doi: 10.1177/03946320140270S103. Int J Immunopathol Pharmacol. 2014. PMID: 24774505 Free article. Review.
461 results